Use of plant microbiome to improve yield in high stress environments

VIR -- initial public offering October, 2019

GOSS -- initial public offering February, 2019

GRTS -- initial public offering September, 2018

EFTR -- initial public offering August, 2021

Acquired by Pacific Biosciences (PACB) -- July, 2021

Acquired by Incyte -- May, 2024

Harnessing the regulatory genome to create next-generation molecular therapies

DICE -- initial public offering September, 2021

EBR:ASX -- initial public offering November, 2021

UBX -- initial public offering May, 2018

Acquired by Neumora Therapeutics

Merged with Tempest Therapeutics (Nasdaq: TPST), June 2021

PULM -- reverse merger June, 2015

SNNA -- initial public offering July, 2017